Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?

Published:2017-02-01 Issue:1 Volume:12 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Ma Jie-Tao,Sun Li,Sun Xin,Xiong Zhi-Cheng,Liu Yang,Zhang Shu-Ling,Huang Le-Tian,Han Cheng-Bo

Funder

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-017-0772-5.pdf

Reference21 articles.

1. Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, et al. German Cancer Society. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie. 2011;65(1):39–59. doi: 10.1055/s-0030-1255961 .

2. Zhao L, West BT, Hayman JA, Lyons S, Cease K, Kong FM. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;68(1):103–10.

3. Pijls-Johannesma M, Houben R, Boersma L, Grutters J, Seghers K, Lambin P, et al. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiother Oncol. 2009;91(3):443–8. doi: 10.1016/j.radonc.2009.02.010 .

4. Hayakawa K, Mitsuhashi N, Katano S, Saito Y, Nakayama Y, Sakurai H, et al. High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer. 2001;32(1):81–8.

5. Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103(19):1452–60. doi: 10.1093/jnci/djr325 . Erratum in: J Natl Cancer Inst. 2012;104(1):79.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity;Journal of Medical Imaging and Radiation Oncology;2024-09-03

2. A roadmap for modelling radiation‐induced cardiac disease;Journal of Medical Imaging and Radiation Oncology;2024-07-10

3. Dosimetric Impact of Delineation and Motion Uncertainties on the Heart and Substructures in Lung Cancer Radiotherapy;Clinical Oncology;2024-07

4. Evaluation of Heart Substructures as a Function of Dose and Radiation-Induced Toxicities in Left-Sided Breast Cancer Radiotherapy;European Journal of Cancer Care;2024-01-16

5. A multimodality assessment of the protective capacity of statin therapy in a mouse model of radiation cardiotoxicity;Radiotherapy and Oncology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3